Expert recommendation for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in patients with HIV infection
The outbreak of coronavirus disease 2019(COVID-19) caused by novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic. SARS-CoV-2 vaccination is currently being actively promoted all over the world, which would serve a promising measure to combat the epidemic. HIV-infected patients manifest varying degrees of immunodeficiency and chronic inflammation, who may require a special consideration on vaccine types and timing of immunization depending on specific clinical situations. The present recommendation provides reference for SARS-CoV-2 vaccination in HIV-infected patients.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:60 |
|---|---|
| Enthalten in: |
Zhonghua nei ke za zhi - 60(2021), 7 vom: 01. Juli, Seite 615-618 |
| Sprache: |
Chinesisch |
|---|
| Beteiligte Personen: |
AIDS and Hepatitis C Professional Group, Chinese Society of Infectious Diseases [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 11.10.2021 Date Revised 11.10.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.3760/cma.j.cn112138.20210403-00259 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM33160843X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM33160843X | ||
| 003 | DE-627 | ||
| 005 | 20231225213834.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||chi c | ||
| 024 | 7 | |a 10.3760/cma.j.cn112138.20210403-00259 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1105.xml |
| 035 | |a (DE-627)NLM33160843X | ||
| 035 | |a (NLM)34619837 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a chi | ||
| 100 | 0 | |a AIDS and Hepatitis C Professional Group, Chinese Society of Infectious Diseases |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Expert recommendation for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in patients with HIV infection |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.10.2021 | ||
| 500 | |a Date Revised 11.10.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The outbreak of coronavirus disease 2019(COVID-19) caused by novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic. SARS-CoV-2 vaccination is currently being actively promoted all over the world, which would serve a promising measure to combat the epidemic. HIV-infected patients manifest varying degrees of immunodeficiency and chronic inflammation, who may require a special consideration on vaccine types and timing of immunization depending on specific clinical situations. The present recommendation provides reference for SARS-CoV-2 vaccination in HIV-infected patients | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t Zhonghua nei ke za zhi |d 1957 |g 60(2021), 7 vom: 01. Juli, Seite 615-618 |w (DE-627)NLM000465526 |x 0578-1426 |7 nnns |
| 773 | 1 | 8 | |g volume:60 |g year:2021 |g number:7 |g day:01 |g month:07 |g pages:615-618 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3760/cma.j.cn112138.20210403-00259 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 60 |j 2021 |e 7 |b 01 |c 07 |h 615-618 | ||